Dahl Andrew M.'s Form 4 filing
Edwards Lifesciences Corp (EW) · filed Aug 31, 2026
- Accession no.
- 0001225208-26-007408
- Filed
- Aug 31, 2026, 5:47 PM ET
- Trade date
- Aug 31, 2026
- Filing delay
- Same day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $49.5K. It was filed on the trade date.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Dahl Andrew M.CIK 0002022347 | Officer (SVP, Corporate Controller) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 31, 2026 | Common Stock | SSaleDisposed | −544 | $91.06 | −$49,533.92 | 14,868.41 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.